TP53 and neoplasm: On most occasions, the reported tumor types matched the patient’s genetic findings, e.g. early-onset breast (family history of patients with findings in BRCA1, BRCA2, BRIP1, NF1), prostate (BRCA2, FANCM, TP53, WT1), renal (TSC1), gynecological (BRIP1, TSC1), and hematological cancers (MLH1, TP53, WT1).